> CTC Story > Application
Global Liquid Biopsy NetworkThe collective CTC data via global networks are processed and accumulated as big data.
CytoGen's Liquid Biopsy PlatformCTC-based liquid biopsy platform is applicable to any stages of anti-cancer drug development procedures.
Clinical Applications using CytoGen’s platformCharacterization of CTCs with specific cancer type biomarkers is available for clinical application
Bile duct Cancer
Head & Neck Cancer
CTC-based biomarkers available at CytoGen
EpCAM/CK/Vimentin+, CD45-, AXL+, HER2+, HER3, Trop2+, PD-L1+, tEGFR+, pEGFR+(Y845), pEGFR+(Y1045), mut.EGFR+(L858R), CD133+, AR-V7+, AR+, PSMA+, Nortch1, pERK+, pEGFR+, pEGFR+, mut.EGFR, EGRFvlll+, GFAP+, PD-L1, PanCK+, FOLR1, HE-4+